Accéder au contenu
Merck

Synthesis and biological activities of reveromycin A and spirofungin A derivatives.

Bioorganic & medicinal chemistry letters (2008-06-04)
Takeshi Shimizu, Takeo Usui, Makoto Fujikura, Makoto Kawatani, Tomoharu Satoh, Kiyotaka Machida, Naoki Kanoh, Je-Tae Woo, Hiroyuki Osada, Mikiko Sodeoka
RÉSUMÉ

Various derivatives of reveromycin A, an inhibitor of eukaryotic cell growth, and spirofungin A, focusing on the 5S hydroxyl group and C18 hemisuccinyl group, were synthesized and their inhibitory effects on both the isoleucyl-tRNA synthetase activity and the survival of osteoclasts, and activities on the morphological reversion of src(ts)-NRK cells were examined. It was found that 2,3-dihydroreveromycin A is the promising derivative of reveromycin A based on the activity and stability.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Reveromycin A, solid